An analysis of Taiwan's National Health Insurance research database has found that long-term use of low-dose aspirin (50–150 mg per day) is associated with a reduced incidence of colorectal cancer (CRC) in patients with high cardiovascular risk. Aspirin users were matched with nonusers and were followed up for a median of 8.9 years. Over this time, 129 nonusers and 14 users of aspirin developed CRC, which corresponds to incidence rates of 180.43 and 79.42 per 100,000 person-years, respectively.
ORIGINAL RESEARCH PAPER
Huang, W.-K. et al. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study. Aliment. Pharmacol. Ther. doi:10.1111/apt.12388
Rights and permissions
About this article
Cite this article
Low doses of aspirin reduce risk of colorectal cancer. Nat Rev Gastroenterol Hepatol 10, 442 (2013). https://doi.org/10.1038/nrgastro.2013.132
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2013.132
